metformin has been researched along with 3-methyladenine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Gao, L; Jiang, T; Shi, JQ; Tan, L; Tan, MS; Wang, HF; Yu, JT; Zhang, QQ; Zhang, YD; Zhu, XC | 1 |
| Cai, N; Chen, D; Feng, Y; Pan, Z; Tang, Q; Tian, N; Wang, C; Wang, Q; Wang, X; Wu, Y; Xia, D; Xu, D; Xu, H; Yan, M; Zhang, JJ; Zhang, X; Zhou, K; Zhou, Y | 1 |
2 other study(ies) available for metformin and 3-methyladenine
| Article | Year |
|---|---|
Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy.
Topics: Adenine; AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Brain; Brain Ischemia; Disease Models, Animal; Hypoglycemic Agents; Male; Metformin; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2014 |
Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo.
Topics: Adenine; Adenylate Kinase; Animals; Apoptosis; Autophagy; Cellular Senescence; Enzyme Activation; Female; Gene Expression Regulation; Intervertebral Disc Degeneration; Male; Metformin; Neuroprotective Agents; Nucleus Pulposus; Oxidative Stress; Rats, Sprague-Dawley; RNA, Small Interfering; tert-Butylhydroperoxide | 2016 |